一种新型冠状病毒mRNA疫苗——初步报告。回复。 - Suppr

Suppr

超能文献

A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply.

作者信息

Jackson Lisa A, Roberts Paul C, Graham Barney S

机构信息

Kaiser Permanente Washington Health Research Institute, Seattle, WA

National Institute of Allergy and Infectious Diseases, Bethesda, MD.

出版信息

N Engl J Med. 2020 Sep 17;383(12):1191-1192. doi: 10.1056/NEJMc2026616. Epub 2020 Aug 19.

DOI:10.1056/NEJMc2026616

PMID:32813942

Abstract

摘要

相似文献

A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply.

N Engl J Med. 2020 Sep 17;383(12):1191-1192. doi: 10.1056/NEJMc2026616. Epub 2020 Aug 19.

A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

N Engl J Med. 2020 Sep 17;383(12):1191. doi: 10.1056/NEJMc2026616. Epub 2020 Aug 19.

A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

N Engl J Med. 2020 Sep 17;383(12):1190-1191. doi: 10.1056/NEJMc2026616. Epub 2020 Aug 19.

COVID-19 and mRNA Vaccines-First Large Test for a New Approach.

JAMA. 2020 Sep 22;324(12):1125-1127. doi: 10.1001/jama.2020.16866.

The Covid-19 Vaccine-Development Multiverse.

N Engl J Med. 2020 Nov 12;383(20):1986-1988. doi: 10.1056/NEJMe2025111. Epub 2020 Jul 14.

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.

Lancet. 2020 Nov 7;396(10261):1486-1487. doi: 10.1016/S0140-6736(20)32267-4.

Vaccine designers take first shots at COVID-19.

Science. 2020 Apr 3;368(6486):14-16. doi: 10.1126/science.368.6486.14.

In Pursuit of a SARS-CoV-2 Vaccine.

J Foot Ankle Surg. 2020 Nov-Dec;59(6):1133-1134. doi: 10.1053/j.jfas.2020.09.011.

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.

Virol Sin. 2020 Jun;35(3):259-262. doi: 10.1007/s12250-020-00243-0. Epub 2020 Jun 10.

Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.

Lancet. 2020 Oct 3;396(10256):e54-e55. doi: 10.1016/S0140-6736(20)31970-X. Epub 2020 Sep 21.

引用本文的文献

THE GORDON WILSON LECTURE: RAPID COVID-19 VACCINE DEVELOPMENT AND THE FUTURE OF VACCINOLOGY.

Trans Am Clin Climatol Assoc. 2023;133:103-105.

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.

medRxiv. 2023 Jan 28:2023.01.25.23284971. doi: 10.1101/2023.01.25.23284971.

Intranasal delivery of a chimpanzee adenovirus vector expressing a pre-fusion spike (BV-AdCoV-1) protects golden Syrian hamsters against SARS-CoV-2 infection.

Front Cell Infect Microbiol. 2022 Nov 3;12:979641. doi: 10.3389/fcimb.2022.979641. eCollection 2022.

Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects.

Front Immunol. 2022 Aug 26;13:922301. doi: 10.3389/fimmu.2022.922301. eCollection 2022.

Recent Updates on mRNA Vaccines.

Vaccines (Basel). 2022 Jul 29;10(8):1209. doi: 10.3390/vaccines10081209.

High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.

Mod Pathol. 2022 Aug;35(8):1013-1021. doi: 10.1038/s41379-022-01069-9. Epub 2022 Apr 1.

A framework and road map for rapid start-up and completion of a COVID-19 vaccine trial: A single clinical trial site experience.

J Clin Transl Sci. 2022 Jan 12;6(1):e21. doi: 10.1017/cts.2022.3. eCollection 2022.

Expression of Human ACE2 N-terminal Domain, Part of the Receptor for SARS-CoV-2, in Fusion With Maltose-Binding Protein, Ribonuclease I and Human RNase A.

Front Microbiol. 2021 Jun 11;12:660149. doi: 10.3389/fmicb.2021.660149. eCollection 2021.

Human IgG and IgA responses to COVID-19 mRNA vaccines.

PLoS One. 2021 Jun 16;16(6):e0249499. doi: 10.1371/journal.pone.0249499. eCollection 2021.

Selective and noncovalent targeting of RAS mutants for inhibition and degradation.

Nat Commun. 2021 May 11;12(1):2656. doi: 10.1038/s41467-021-22969-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply.

N Engl J Med. 2020 Sep 17;383(12):1191-1192. doi: 10.1056/NEJMc2026616. Epub 2020 Aug 19.

A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

N Engl J Med. 2020 Sep 17;383(12):1191. doi: 10.1056/NEJMc2026616. Epub 2020 Aug 19.

A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

N Engl J Med. 2020 Sep 17;383(12):1190-1191. doi: 10.1056/NEJMc2026616. Epub 2020 Aug 19.

COVID-19 and mRNA Vaccines-First Large Test for a New Approach.

JAMA. 2020 Sep 22;324(12):1125-1127. doi: 10.1001/jama.2020.16866.

The Covid-19 Vaccine-Development Multiverse.

N Engl J Med. 2020 Nov 12;383(20):1986-1988. doi: 10.1056/NEJMe2025111. Epub 2020 Jul 14.

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.

Lancet. 2020 Nov 7;396(10261):1486-1487. doi: 10.1016/S0140-6736(20)32267-4.

Vaccine designers take first shots at COVID-19.

Science. 2020 Apr 3;368(6486):14-16. doi: 10.1126/science.368.6486.14.

In Pursuit of a SARS-CoV-2 Vaccine.

J Foot Ankle Surg. 2020 Nov-Dec;59(6):1133-1134. doi: 10.1053/j.jfas.2020.09.011.

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.

Virol Sin. 2020 Jun;35(3):259-262. doi: 10.1007/s12250-020-00243-0. Epub 2020 Jun 10.

Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.

Lancet. 2020 Oct 3;396(10256):e54-e55. doi: 10.1016/S0140-6736(20)31970-X. Epub 2020 Sep 21.

引用本文的文献

THE GORDON WILSON LECTURE: RAPID COVID-19 VACCINE DEVELOPMENT AND THE FUTURE OF VACCINOLOGY.

Trans Am Clin Climatol Assoc. 2023;133:103-105.

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.

medRxiv. 2023 Jan 28:2023.01.25.23284971. doi: 10.1101/2023.01.25.23284971.

Intranasal delivery of a chimpanzee adenovirus vector expressing a pre-fusion spike (BV-AdCoV-1) protects golden Syrian hamsters against SARS-CoV-2 infection.

Front Cell Infect Microbiol. 2022 Nov 3;12:979641. doi: 10.3389/fcimb.2022.979641. eCollection 2022.

Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects.

Front Immunol. 2022 Aug 26;13:922301. doi: 10.3389/fimmu.2022.922301. eCollection 2022.

Recent Updates on mRNA Vaccines.

Vaccines (Basel). 2022 Jul 29;10(8):1209. doi: 10.3390/vaccines10081209.

High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.

Mod Pathol. 2022 Aug;35(8):1013-1021. doi: 10.1038/s41379-022-01069-9. Epub 2022 Apr 1.

A framework and road map for rapid start-up and completion of a COVID-19 vaccine trial: A single clinical trial site experience.

J Clin Transl Sci. 2022 Jan 12;6(1):e21. doi: 10.1017/cts.2022.3. eCollection 2022.

Expression of Human ACE2 N-terminal Domain, Part of the Receptor for SARS-CoV-2, in Fusion With Maltose-Binding Protein, Ribonuclease I and Human RNase A.

Front Microbiol. 2021 Jun 11;12:660149. doi: 10.3389/fmicb.2021.660149. eCollection 2021.

Human IgG and IgA responses to COVID-19 mRNA vaccines.

PLoS One. 2021 Jun 16;16(6):e0249499. doi: 10.1371/journal.pone.0249499. eCollection 2021.

Selective and noncovalent targeting of RAS mutants for inhibition and degradation.

Nat Commun. 2021 May 11;12(1):2656. doi: 10.1038/s41467-021-22969-5.